Bruker
Products & Solutions
Applications
Services
News & Events
About
Careers

Rapid Narcotics Analysis by Orthogonal Methods: MS meets NMR

Detection of illegal drugs is an ongoing battle and the rapid analysis and identification of prohibited substances is critical to prevent their importation and widespread distribution.

Detection of illegal drugs is an ongoing battle and the rapid analysis and identification of prohibited substances is critical to prevent their importation and widespread distribution. Additionally, the data generated needs to be significantly robust for submission in court cases. In most countries across the globe, a minimum of two orthogonal analytical methods must be used in drug testing to provide detailed and admissible evidence. Nuclear Magnetic Resonance and Mass Spectrometry are well established key methods for narcotics analysis, and operate on fundamentally different scientific principles, thus providing definitive identifications. Both methods validate each other and are now brought to your lab bench by Bruker. Today, Bruker’s powerful approach provides enhanced ease of use and maximized method compliance. Bruker supports leading law enforcement authorities worldwide. Become part of the community!

Key Learning Objectives

  • Increase evidence robustness by application of orthogonal methods
  • Take advantage of training and maintenance synergies from one single point of contact
  • Enhance ease of use and through put with harmonized methods
  • Shorten time to result with benchtop instruments in every local laboratory

Who Should Attend?

This webinar will be of interest to those working in forensic laboratories, law enforcement authorities, customs & border protection agencies, regulatory bodies, official control laboratories and undertaking analysis of narcotics or suspected narcotics.

Speakers

Dr. Venita Decker

Product Manager FT-NMR benchtop solutions, BBIO, Bruker BioSpin, Rheinstetten, Germany

Dr. Venita Decker studied Neuroscience, but did her dissertation in the field of solid-state NMR (Max Planck Institute for Biophysical Chemistry, Goettingen). In 2012, she joined the Bruker solid-state NMR application. As a NMR-late entrant she since then actively supported Bruker solutions that simplify the complexity of NMR (TopSolids, the minispec FormCheck). Since 2018, she is the Product Manager for FT-NMR benchtop solutions, bringing her mission to the next level.